Mesoporous Colloidal Photonic Crystal Particles for Intelligent Drug Delivery.

Particle-based delivery systems demonstrate a pregnant value in the fields of drug research and development. Efforts to advance this technology focus on the fabrication of functional particles with enhanced efficiency and performance for drug delivery. Here, we present a new type of mesoporous colloidal photonic crystal particle (MCPCP)-based drug-delivery system with distinct features. As the MCPCPs were constructed by self-assembling monodisperse mesoporous nanoparticles in microfluidic droplet templates, they were composed of hierarchical macro- and mesoporous structures and could provide plenty of nanopores and interconnected nanochannels for synergistic loading of both micro- and macromolecule drugs with large quantity and sustained release. In addition, by integrating the stimuli-responsive poly( N-isopropylacrylamide) hydrogel into the MCPCPs and employing it as a "gating" to control the opening of the macro- and mesopores, the MCPCP delivery systems were imparted with the function of controllable release. More attractively, as the average refractive index of the MCPCPs was decreased during the release of the loaded actives, the photonic band gaps of the MCPCPs blue-shifted correspondingly; this provided a novel stratagem for real-time self-reporting of the therapeutic agent release process of the MCPCPs. Hence, the MCPCPs are ideal for intelligent drug delivery because of these dramatical features.